Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats
- 17 April 2014
- journal article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 19 (2) , 168-177
Abstract
Currently kidney disease appears a foremost problem across the world. Acetaminophen is a commonly used antipyretic agent, which in high doses, causes uremia and used for experimentally induction of kidney disease. Bacteriotherapy affords a promising approach to mitigate uremic toxins by ingestion of urease positive bacteria, probiotics and symbiotic able to catabolize uremic solutes within the gut. The present study evaluates the effect of seven commercial symbiotic on kidney disease. Fifty-four albino male rats were randomly divided into nine groups. Control group (Group-I) received distilled water interperitoneally for 7 days. Positive control group (Group-II) received 500 mg/kg acetaminophen interperitoneally for 7 days. Commercially available seven symbiotic combinations at a dose of 109cells/day for 3 weeks was administered to the tested groups (Group III–IX) after receiving 500 mg/kg/day acetaminophen interperitoneally for 7 days. Blood, kidney, liver and stool samples were collected after scarification for biochemical tests and DNA fragmentation assay of kidney tissue, kidney histological studies. Limited fecal analysis was conducted. Blood urea nitrogen and toxicity indicators were increased, and antioxidant enzymes were decreased in Group-II. Blood urea nitrogen, toxicity indicators, glomerular necrosis, DNA damage of kidney tissue were reduced, and antioxidant enzymes were increased significantly in the treated Groups IV and IX (p < 0.05) in response to Group-II. Number of pathogenic bacteria decreased in synbiotic treated groups than Group I and II. The study demonstrated that some of commercial symbiotic combination can reduce the sever effect of kidney disease.Keywords
This publication has 30 references indexed in Scilit:
- In vivo assessment of bacteriotherapy on acetaminophen-induced uremic ratsJournal Of Nephrology, 2012
- Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivationToxicology, 2010
- Paracetamol-Induced Renal Tubular InjuryJournal of the American Society of Nephrology, 2004
- Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cellsExperimental and Toxicologic Pathology, 2002
- Dose-Dependent Protection by Lipoic Acid against Cisplatin-Induced Nephrotoxicity in Rats: Antioxidant Defense SystemBasic & Clinical Pharmacology & Toxicology, 2000
- Inhibition of Lipid Peroxidation byLactobacillus acidophilusandBifidobacterium longumJournal of Agricultural and Food Chemistry, 1999
- Reactive Oxygen Species Participate in Peroxynitrite-Induced Apoptosis in HL-60 CellsBiochemical and Biophysical Research Communications, 1997
- Inhibition of the Accumulation of Uremic Toxins in the Blood and Their Precursors in the Feces after Oral Administration of Lebenin®, a Lactic Acid Bacteria Preparation, to Uremic Patients Undergoing HemodialysisNephron, 1996
- Acetaminophen Nephrotoxicity in CD-1 MiceToxicology and Applied Pharmacology, 1994
- Paracetamol poisoning and the kidneyJournal of Clinical Pharmacy and Therapeutics, 1993